The Role of Sphingosine-1-Phosphate Transporter <i>Spns2</i> in Immune System Function

Anastasia Nijnik(University of British Columbia), Simon Clare(Wellcome Sanger Institute), Christine Hale(Wellcome Sanger Institute), Jing Chen(Wellcome Sanger Institute), Claire Raisen(Wellcome Sanger Institute), Lynda Mottram(Wellcome Sanger Institute), Mark Lucas(Wellcome Sanger Institute), Jeanne Estabel(Wellcome Sanger Institute), Edward J. Ryder(Wellcome Sanger Institute), Hibret A. Adissu(Toronto Centre for Phenogenomics), Sanger Mouse Genetics Project, Allan Bradley(Wellcome Sanger Institute), Ramiro Ramírez‐Solis(Wellcome Sanger Institute), David J. Adams(Wellcome Sanger Institute), Jacqueline K White(Wellcome Sanger Institute), Niels C Adams(Wellcome Sanger Institute), Karen P. Steel(Wellcome Sanger Institute), Bill Skarnes(Wellcome Sanger Institute), Gordon Dougan(Wellcome Sanger Institute), David Melvin, David Gannon(Wellcome Sanger Institute), Mark Griffiths, Christian Kipp, Arthur Evans(Wellcome Sanger Institute), S. Holroyd, Caroline Barnes, Emma L. Cambridge, Damian M. Carragher(Wellcome Sanger Institute), Simon Clare(Wellcome Sanger Institute), Kay Clarke, Hayley Protheroe(Wellcome Sanger Institute), Jeanne Estabel(Wellcome Sanger Institute), Anna-Karin Gerdin, Yvette Hooks, Natalia Igosheva, Ozama Ismail, Leanne Kane, Natasha A. Karp, David Lafont(Wellcome Sanger Institute), Mark Lucas(Wellcome Sanger Institute), Simon Maguire, Katherine McGill(Wellcome Sanger Institute), Lynda Mottram(Wellcome Sanger Institute), Lee Mulderrig(Wellcome Sanger Institute), Christine Podrini, Hayley Protheroe, Laura Roberson, Grace Salsbury, Daniel Sanger(Wellcome Sanger Institute), Mark Sanderson, Carl Shannon, David Sunter, Elizabeth Tuck, Valerie E. Vancollie, Debarati Bhattacharjee, Ross Cook, Diane Gleeson, Matthew Hardy(Wellcome Sanger Institute), Claire Haskins, Kalpesh Jhaveri, Stacey Price(Wellcome Sanger Institute), Edward J. Ryder(Wellcome Sanger Institute), Debarati Sethi, Sapna Vyas, Joanna Bottomley, Ellen Brown, James Bussell, Evelyn Grau, Richard Houghton, Helen Kundi, Alla Madich, Danielle Mayhew, Tom Metcalf, Stuart Newman, Laila Pearson, Caroline Sinclair, Hannah Wardle‐Jones, Mike Woods(Wellcome Sanger Institute), Niels C Adams(Wellcome Sanger Institute), Ramiro Ramírez‐Solis(Wellcome Sanger Institute), Jacqueline K White(Wellcome Sanger Institute), Karen P. Steel(Wellcome Sanger Institute), Gordon Dougan(University of British Columbia), Robert E. W. Hancock(University of British Columbia)
The Journal of Immunology
June 5, 2012
Cited by 98Open Access
Full Text

Abstract

Sphingosine-1-phosphate (S1P) is lipid messenger involved in the regulation of embryonic development, immune system functions, and many other physiological processes. However, the mechanisms of S1P transport across cellular membranes remain poorly understood, with several ATP-binding cassette family members and the spinster 2 (Spns2) member of the major facilitator superfamily known to mediate S1P transport in cell culture. Spns2 was also shown to control S1P activities in zebrafish in vivo and to play a critical role in zebrafish cardiovascular development. However, the in vivo roles of Spns2 in mammals and its involvement in the different S1P-dependent physiological processes have not been investigated. In this study, we characterized Spns2-null mouse line carrying the Spns2(tm1a(KOMP)Wtsi) allele (Spns2(tm1a)). The Spns2(tm1a/tm1a) animals were viable, indicating a divergence in Spns2 function from its zebrafish ortholog. However, the immunological phenotype of the Spns2(tm1a/tm1a) mice closely mimicked the phenotypes of partial S1P deficiency and impaired S1P-dependent lymphocyte trafficking, with a depletion of lymphocytes in circulation, an increase in mature single-positive T cells in the thymus, and a selective reduction in mature B cells in the spleen and bone marrow. Spns2 activity in the nonhematopoietic cells was critical for normal lymphocyte development and localization. Overall, Spns2(tm1a/tm1a) resulted in impaired humoral immune responses to immunization. This study thus demonstrated a physiological role for Spns2 in mammalian immune system functions but not in cardiovascular development. Other components of the S1P signaling network are investigated as drug targets for immunosuppressive therapy, but the selective action of Spns2 may present an advantage in this regard.


Related Papers

No related papers found

Powered by citation graph analysis